Ruptured corpus luteum cysts and anticoagulant therapy

International Journal of Gynecology and Obstetrics

Volumn 76, Issue 3, 2002, Pages 319-320

  Jamal, A ^a   Mesdaghinia, S ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticoagulants; Oral contraceptives; Ruptured corpus luteum cysts

Indexed keywords

ANTICOAGULANT AGENT; LOW DOSE ORAL CONTRACEPTIVE; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; CYST RUPTURE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HEART VALVE PROSTHESIS; HEMODYNAMICS; HEMOGLOBIN DETERMINATION; HEMOPERITONEUM; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; ORAL CONTRACEPTION; OVARIECTOMY; OVARY CYST; OVARY FUNCTION; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROTHROMBIN TIME; RECURRENT DISEASE; RISK; SUTURE; THROMBOSIS; UTERUS BLEEDING;

EID: 0036191851     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(01)00534-3     Document Type: Article

References (3)

1. Hemostasis profile in women taking low dose oral contraceptives
2. Changes in coagulation and anticoagulation in women taking low- dose triphasic oral contraceptives: A controlled, comparative, 12-month clinical trial
3. Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen